Dr. Soliman Abdel Kader Fakeeh Hospital Co. Announces Board approval to initiate negotiations to acquire majority stake in Diagnostic Elite Company
| Element List | Explanation |
|---|---|
| Announcement Detail | Dr. Soliman Abdulkader Fakeeh Hospital Company ("DSFH") and its subsidiaries ("Fakeeh Care Group", "Group", "Fakeeh Care") is pleased to announce that the Board of Directors, on 4th of November 2025, has approved the initiation of negotiations to acquire a majority stake in Diagnostic Elite Company (“DE”) whereby it becomes a subsidiary of DSFH.
This acquisition is intended to come by way of an assignment by an affiliate, Sulaiman Abdul-Qader Fakeeh Real Estate Co. (related party), of 50.01% of its investment in DE in favor of DSFH. This transaction aims to ensure that DE’s service offerings further integrate within the Group’s core healthcare platform.
This transaction is subject to the regulatory approvals and necessary procedures to complete the assignment between DSFH and Sulaiman Abdul-Qader Fakeeh Real Estate Co. (related party). Further material developments will be announced in accordance with applicable regulations. |
Comments